We found 3 drugmaker programs for Primary Biliary Cholangitis medicines and 2 charity funds (1 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Primary Biliary Cholangitis depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Out-of-pocket costs for approved medications. Up to $2,500 a year.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
Iqirvo Copay Assistance Program: eligible commercially insured patients may pay as little as $0. An annual calendar-year maximum applies. Not available to patients enrolled in Medicare Part B or D, Medicaid, Medigap, VA, DoD, TRICARE or other state or federal programs, or to patients using another assistance program, foundation or free trial in the same enrollment year.
A dedicated Patient Access Manager helps with insurance coverage and identifies possible financial support programs; Patient Education Liaisons provide education on PBC and Iqirvo. Enrollment requires a form from the doctor and a signed patient authorization.
Hours Monday to Friday, 8 AM to 8 PM ET; email support@ipsencares.com. A free-drug program for uninsured patients was not described on the Iqirvo page, so none is listed.
Livdelzi Co-pay Savings Program: eligible commercially insured patients may pay as little as $0, with savings of up to $10,000 a year and no monthly limit. For commercially insured eligible patients only; additional restrictions apply.
Support Path offers insurance benefits investigation, prior authorization and appeals information, and education on Medicare Part D and the Medicare Prescription Payment Plan.
Support Path can connect eligible uninsured patients to Gilead's Patient Assistance Program.
Phone is 1-855-7-MYPATH. Full co-pay terms are posted at mysupportpath.com/co-pay, which timed out when fetched; offer details were taken from livdelzi.com and livdelzihcp.com. Patient Assistance Program income limits were not confirmed.
Interconnect Savings Program: patients with commercial insurance may pay as little as $0 a month for Lynavoy. Not valid for patients enrolled in Medicare, DoD, VA, Medicaid or other federal or state healthcare programs.
Interconnect Care Managers explain benefits, explore other coverage and financial assistance options, and give ongoing support such as check-ins and refill reminders. Prescriptions are filled through PANTHERx Rare Pharmacy (1-866-347-0951).
Lynavoy is marketed by Intercept Pharmaceuticals, a subsidiary of Alfasigma, which licensed linerixibat from GSK (deal closed April 27, 2026). Full co-pay terms are at interconnectsupport.com/en/copay-terms, which timed out when fetched. Specific free-drug or bridge terms were not confirmed.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 3 drugmaker programs for Primary Biliary Cholangitis medicines and 2 charity funds, 1 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Primary Biliary Cholangitis, 1 charity fund on this page accepts Medicare (1 open at our last check), and 0 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
At our last check, TotalAssist's Primary Biliary Cholangitis fund was open to new applicants. Funds open and close as donations come in, so check the foundation's page before you apply.
Of the drugmaker programs for Primary Biliary Cholangitis medicines, 1 offers free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (TotalAssist, The Assistance Fund) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
